Objective-To study risk factors for hepatitis C virus (HCV) infection
in injecting drug users (IDUs) from central Sydney. Setting and subjec
ts-All IDUs attending a primary health care facility in central Sydney
between December 1991 and November 1992 who underwent HCV antibody te
sting. Methods-Information was obtained retrospectively from client fo
rms routinely completed at the time of medical consultation. Additiona
l information on injecting history and practice was obtained from the
registration forms of subjects who also attended the needle syringe ex
change programme at the same health care facility. Results-Of the 201
IDUs tested, 118 (59%) had HCV antibodies, which did not differ signif
icantly between males and females. HCV prevalence increased significan
tly with age, being highest in IDUs who were aged 35 years or more (93
%) and lowest in IDUs aged under 20 years (17%). HCV prevalence increa
sed significantly with time since first injecting, from 26% for IDUs w
ho had injected for less than 3 years to 94% for those who had injecte
d for more than 10 years. HCV prevalence was also significantly higher
in heterosexual IDUs as compared with homosexual male IDUs, and in op
iate users as compared with stimulant users, even after adjustment for
age and duration of injecting. HCV prevalence was strongly associated
with exposure to hepatitis B virus, but was not associated with expos
ure to HIV. Conclusion-Recent HCV transmission indicates ongoing injec
ting risk behaviour despite HIV prevention efforts, and underlies the
potential for increased transmission of HIV through the sharing of inj
ecting equipment. Within the population of IDUs, those who are heteros
exual or inject heroin appear to be at increased risk of HCV infection
.